Related Experiment Videos
Receptors in disease: an overview
1Department of Laboratory Medicine, Osaka University Medical School, Japan.
Clinical Biochemistry
|February 1, 1990
Summary
Receptor abnormalities, including congenital defects, postreceptor issues, and acquired antibodies, disrupt hormone signaling and cause various diseases like familial hypercholesteremia and myasthenia gravis.
Area of Science:
- Endocrinology and Molecular Biology
- Cellular Signaling Mechanisms
- Immunology and Disease Pathophysiology
Background:
- Hormones and signal molecules exert physiological effects by binding to cellular receptors.
- Understanding receptor function is crucial for diagnosing and treating numerous diseases.
- Receptor abnormalities represent a significant area of study in human health.
Purpose of the Study:
- To categorize and describe the different types of receptor-related abnormalities.
- To highlight examples of diseases associated with specific receptor defects.
- To underscore the role of receptor dysfunction in various pathological conditions.
Main Methods:
- Review and synthesis of current knowledge on receptor biology and related disorders.
- Classification of receptor abnormalities into congenital, postreceptor, and acquired categories.
- Illustration with specific clinical examples such as familial hypercholesteremia, androgen resistance, pseudohypoparathyroidism, Graves' disease, and myasthenia gravis.
Main Results:
- Identified three primary categories of receptor abnormalities: congenital, postreceptor coupling, and acquired.
- Provided examples for each category, including LDL receptor defects, guanine nucleotide-binding protein issues, and antireceptor antibodies.
- Linked these abnormalities to specific diseases, demonstrating their pathophysiological significance.
Conclusions:
- Receptor abnormalities are diverse, ranging from genetic defects to autoimmune responses.
- These abnormalities disrupt essential signaling pathways, leading to a spectrum of clinical manifestations.
- Further research into receptor mechanisms is vital for developing targeted therapies for related diseases.